Title:
アミノアルコール誘導体
Document Type and Number:
Japanese Patent JP2004509162
Kind Code:
A
Abstract:
The present invention relates to a compound formula (I) wherein X1 is bond or -O-CH2-, (II) or (III) R<1 >is hydrogen or an amino protective group, a is phenyl, indolyl or carbazolyl, each of which may be substituted with one or two substituent(s), and B is hydrogen; halogen; lower alkyl; lower alkoxycarbonyl; cyclo(lower)alkyl; or a heterocyclic group, naphthyl, 1,2,3,4-tetrahydronaphthyl, benzyl or phenyl, each of which may be substituted with one or two substituent(s), or a salt thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiures or urinary incontinence.
Inventors:
Minoru Sakurai
Kenichi Washizuka
Hitoshi Hamajima
Yasuyo Tomijima
Masashi Imanishi
Yutaka Nakajima
Hiroaki Otake
Satoshi Kuroda
Murata Masayoshi
Hiroshi Kayakiri
Naoaki Fujii
Kiyoshi Taniguchi
Kenichi Washizuka
Hitoshi Hamajima
Yasuyo Tomijima
Masashi Imanishi
Yutaka Nakajima
Hiroaki Otake
Satoshi Kuroda
Murata Masayoshi
Hiroshi Kayakiri
Naoaki Fujii
Kiyoshi Taniguchi
Application Number:
JP2002528649A
Publication Date:
March 25, 2004
Filing Date:
September 19, 2001
Export Citation:
Assignee:
Fujisawa Pharmaceutical Co., Ltd.
International Classes:
A61K31/167; A61K31/17; A61K31/18; A61K31/216; A61K31/327; A61K31/341; A61K31/381; A61K31/40; A61K31/404; A61K31/415; A61K31/4184; A61K31/421; A61K31/426; A61K31/4406; A61K31/4409; A61K31/47; A61K31/472; A61K31/498; A61P1/00; A61P3/00; A61P3/04; A61P3/10; A61P9/00; A61P13/00; A61P13/02; C07C53/18; C07C231/02; C07C231/08; C07C231/10; C07C233/36; C07C233/43; C07C233/62; C07C233/75; C07C233/80; C07C235/56; C07C273/02; C07C275/40; C07C275/42; C07C275/54; C07C303/38; C07C311/08; C07D207/34; C07D207/416; C07D209/08; C07D209/18; C07D209/40; C07D209/42; C07D209/88; C07D213/40; C07D213/56; C07D213/75; C07D213/81; C07D213/82; C07D215/38; C07D215/40; C07D215/48; C07D215/50; C07D217/18; C07D217/22; C07D217/26; C07D231/14; C07D231/56; C07D233/90; C07D235/06; C07D235/08; C07D235/16; C07D237/28; C07D241/20; C07D241/42; C07D241/44; C07D249/08; C07D261/14; C07D261/18; C07D261/20; C07D263/18; C07D263/34; C07D277/28; C07D277/56; C07D295/215; C07D307/54; C07D307/66; C07D307/68; C07D307/82; C07D333/36; C07D333/38; C07D333/66; C07D333/70; C07D487/04; C07D207/40; (IPC1-7): C07C233/36; A61K31/167; A61K31/17; A61K31/18; A61K31/216; A61K31/327; A61K31/341; A61K31/381; A61K31/40; A61K31/404; A61K31/415; A61K31/4184; A61K31/421; A61K31/426; A61K31/4406; A61K31/4409; A61K31/47; A61K31/472; A61K31/498; A61P3/04; A61P3/10; A61P13/02; C07C53/18; C07C231/02; C07C231/08; C07C231/10; C07C233/62; C07C233/75; C07C233/80; C07C273/02; C07C275/40; C07C303/38; C07C311/08; C07D207/34; C07D209/08; C07D213/56; C07D213/82; C07D215/48; C07D217/18; C07D231/14; C07D235/16; C07D241/42; C07D263/18; C07D277/28; C07D307/68; C07D333/38; C07D333/70
Attorney, Agent or Firm:
Eiji Tafushi